PEPTIDE
Verified ComparisonLast updated: 19 April 2026

Best Peptides for Immune Research

Immune peptides target different pathways; this overview ranks candidates by clinical evidence and mechanism.

Compound A

Thymosin Alpha-1

Immune

Evidence
3.9/ 5
B+

Compound B

KPV

Immune

Evidence
3.6/ 5
B
Editor's note
Thymosin-alpha-1 has established clinical pathways; KPV offers emerging immune barrier support.
CriterionThymosin Alpha-1KPV
Thymic and immune pathwayWell-establishedEmerging
Clinical trial dataSome approved-context trialsVery limited
Barrier function focusIndirectDirect (intestinal/immune barrier)
Regulatory pathway (AU)Defined indicationResearch-only

Want to read the full reviews?